I have acquired a small parcel of STI share over the past two years or so as I believe the potential upside of this stock is enormous.
After analysing their activities in the past few months, these are my thoughts.
I believe ( bl##dy well hope so) that their short term focus is to establish a steady income which will give them the ability to get cracking with Immunoxel establishment into the bigger market and their obesity products including R-Salbutamol. One would also predict that they will generate early income from the Canadian Pharmaceutical Plant Acquisition which is certainly a golden egg for the company.
What keeps me interested in the company are the following:
Immunoxel- if STI can make this the ?new? vitamin C or Echinacea than we can all buy a yacht and sail home.
R-Salbutamol -Obesity (and diabetes) is well and truly the major concern for Australia/America and we are now been advised that obesity is a growing concern in India. If STI can tap into the obesity market things will be looking rosy indeed.
Lets hope they will give us a time line indicating their goals in the near future.
One niggling problem that I have encounter is finding the website. Do a google search on Stirling health products?very hard to find STI?s webpage when there are two other companies with almost identical names. I think a company name change would be a good idea. A bit of a general tidy up of the website might help as well?they might need to consult a professional!
Here is the problem-
www.stirlingproducts.net (Stirling products limited ASX: STI)
www.stirlingproducts.com.au (Stirling products Australia, web site dates back to 2000 and does not appear to be affiliated with STI).
http://www.stirling-health.net (UK company, again nothing to do with STI ?)
Looking to the future with anticipation of good things to come!
Add to My Watchlist
What is My Watchlist?